Pharmaceuticals, Biotechnology and Life Sciences
The UN Political Declaration has for a goal to treat 40 million people for TB disease in the 5-year period 2018-22, and 7 million have already been treated in 2018.
Genentech has received FDA’s approval of Xofluza, which is the first and only antiviral medicine indicated specifically for patients at…
Acerus Pharmaceuticals said Thursday in a press release that new data showed that Natesto increases serum testosterone and improves symptoms…
Inversago has welcomed Dennis Kim, MD, MBA and Tara Nickerson, PhD, MBA as new independent directors, following its goal to…
Cadent Therapeutics has named Dawn Wilson appointed as Vice President, Clinical Operations, as it releases the data from Phase 2…
MELBOURNE, Australia–(BUSINESS WIRE)–Neuren Pharmaceuticals (ASX: NEU) today announced that the US Food and Drug Administration (FDA) has granted Orphan Drug…
San Diego based Plexium on Thursday launched the company with $28 Million in series A financing, aimed for advance its DELPhe platform to discover novel E3 ligase-modulating therapeutics to treat cancer and neurodegenerative diseases.
Shinogoi might have cefiderocol approved by the US FDA, as the Advisory Committee reccomends it for treatment of complicated urinary…
VANCOUVER, British Columbia–(BUSINESS WIRE)–Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical company developing multifunctional therapeutics, today announced the appointment of Kathryn…